Verition Fund Management
ACGN

Verition Fund Management’s Aceragen Inc ACGN Stock Holding History

Verition Fund Management’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-88
Closed -$35K – 906
2014
Q2 		$35K Sell
88
-1
-1% -$412 ﹤0.01% 645
2014
Q1 		$49K Buy
+89
New +$60.9K 0.01% 470

Other funds holding ACGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Verition Fund Management's ACGN Position: Q3 2014 in Review

Verition Fund Management sold out of Aceragen Inc (ACGN) in Q3 2014, closing a stake of 88 shares — an estimated $35K sold.

Verition Fund Management first reported a position in ACGN in Q1 2014 and held it in 2 quarters. The position peaked at $49K in Q1 2014. 62 funds tracked by Wall St. Rank hold ACGN as of Q3 2014.

  • Verition Fund Management reported no remaining Aceragen Inc position as of Q3 2014 after selling out during the quarter.
  • Verition Fund Management sold 88 Aceragen Inc shares in Q3 2014, an estimated $35K.
  • Verition Fund Management first reported a position in Aceragen Inc in Q1 2014 and held it in 2 quarters.
  • Verition Fund Management's Aceragen Inc position peaked at $49K in Q1 2014.
  • 62 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2014.

Based on Verition Fund Management's 13F filing for Q3 2014, filed 14 Nov 2014.